Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by symbiont of host defense response (GO:0052031) | 5.08492220 |
2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.08492220 |
3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.08492220 |
4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.08492220 |
5 | modulation by symbiont of host immune response (GO:0052553) | 5.08492220 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.08492220 |
7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.00058964 |
8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.75234168 |
9 | negative regulation of cell killing (GO:0031342) | 4.75234168 |
10 | response to peptidoglycan (GO:0032494) | 4.47662413 |
11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.45795855 |
12 | NIK/NF-kappaB signaling (GO:0038061) | 4.27486204 |
13 | neutrophil activation involved in immune response (GO:0002283) | 4.27196060 |
14 | positive regulation of interferon-alpha production (GO:0032727) | 4.19811124 |
15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.06180975 |
16 | response to muramyl dipeptide (GO:0032495) | 4.04978760 |
17 | regulation of interferon-alpha production (GO:0032647) | 4.01508391 |
18 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.91370646 |
19 | macrophage activation involved in immune response (GO:0002281) | 3.82462018 |
20 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.75782414 |
21 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.75223604 |
22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.70469565 |
23 | cellular extravasation (GO:0045123) | 3.67651768 |
24 | positive regulation of heat generation (GO:0031652) | 3.62983928 |
25 | detection of other organism (GO:0098543) | 3.61999921 |
26 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.56418895 |
27 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.56296847 |
28 | detection of external biotic stimulus (GO:0098581) | 3.53475118 |
29 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.52507079 |
30 | natural killer cell mediated immunity (GO:0002228) | 3.52507079 |
31 | response to type I interferon (GO:0034340) | 3.51660749 |
32 | cellular response to type I interferon (GO:0071357) | 3.49753093 |
33 | type I interferon signaling pathway (GO:0060337) | 3.49753093 |
34 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.49382927 |
35 | response to host immune response (GO:0052572) | 3.49382927 |
36 | negative regulation of T cell mediated immunity (GO:0002710) | 3.45770902 |
37 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.45579841 |
38 | positive regulation of interleukin-12 production (GO:0032735) | 3.39489547 |
39 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.37751316 |
40 | negative regulation of lipid storage (GO:0010888) | 3.36610201 |
41 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.36331008 |
42 | T-helper 1 type immune response (GO:0042088) | 3.33795560 |
43 | regulation of fever generation (GO:0031620) | 3.31125583 |
44 | granulocyte activation (GO:0036230) | 3.30878633 |
45 | B cell receptor signaling pathway (GO:0050853) | 3.29866606 |
46 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.29489845 |
47 | response to interleukin-15 (GO:0070672) | 3.25699910 |
48 | detection of bacterium (GO:0016045) | 3.25648286 |
49 | positive regulation of interferon-beta production (GO:0032728) | 3.25082879 |
50 | cellular response to ethanol (GO:0071361) | 3.25054716 |
51 | negative thymic T cell selection (GO:0045060) | 3.24806599 |
52 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.22852489 |
53 | negative T cell selection (GO:0043383) | 3.22549974 |
54 | neutrophil activation (GO:0042119) | 3.20526442 |
55 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.19910675 |
56 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.19746468 |
57 | detection of molecule of bacterial origin (GO:0032490) | 3.17676361 |
58 | I-kappaB phosphorylation (GO:0007252) | 3.16938811 |
59 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.15553427 |
60 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.15329585 |
61 | cellular response to virus (GO:0098586) | 3.15292281 |
62 | response to host (GO:0075136) | 3.14523600 |
63 | response to host defenses (GO:0052200) | 3.14523600 |
64 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.14523600 |
65 | positive regulation of humoral immune response (GO:0002922) | 3.13729938 |
66 | positive regulation of antigen processing and presentation (GO:0002579) | 3.13373642 |
67 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.13351462 |
68 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.13351462 |
69 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.11302693 |
70 | immunoglobulin mediated immune response (GO:0016064) | 3.09517905 |
71 | detection of biotic stimulus (GO:0009595) | 3.08456018 |
72 | microglial cell activation (GO:0001774) | 3.06475844 |
73 | myeloid dendritic cell differentiation (GO:0043011) | 3.05686433 |
74 | cellular response to interleukin-15 (GO:0071350) | 3.05366142 |
75 | regulation of RIG-I signaling pathway (GO:0039535) | 3.03192353 |
76 | respiratory burst (GO:0045730) | 3.02637286 |
77 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.02539957 |
78 | regulation of chemokine biosynthetic process (GO:0045073) | 3.02334752 |
79 | cytokine secretion (GO:0050663) | 3.00717754 |
80 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.99595819 |
81 | defense response to protozoan (GO:0042832) | 2.98349885 |
82 | superoxide anion generation (GO:0042554) | 2.98198725 |
83 | germinal center formation (GO:0002467) | 2.96354351 |
84 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.94820918 |
85 | myeloid cell activation involved in immune response (GO:0002275) | 2.91580635 |
86 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.89892217 |
87 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.89559512 |
88 | cellular response to interferon-beta (GO:0035458) | 2.89251826 |
89 | modulation by symbiont of host cellular process (GO:0044068) | 2.88530537 |
90 | myeloid dendritic cell activation (GO:0001773) | 2.88352252 |
91 | positive thymic T cell selection (GO:0045059) | 2.87592220 |
92 | regulation of interleukin-12 production (GO:0032655) | 2.87071394 |
93 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.85943070 |
94 | positive T cell selection (GO:0043368) | 2.85113557 |
95 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.84249618 |
96 | regulation of activation of Janus kinase activity (GO:0010533) | 2.83651636 |
97 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.83396288 |
98 | response to protozoan (GO:0001562) | 2.83376157 |
99 | regulation of antigen processing and presentation (GO:0002577) | 2.80263361 |
100 | cell adhesion mediated by integrin (GO:0033627) | 2.80194535 |
101 | negative regulation of interleukin-12 production (GO:0032695) | 2.79973856 |
102 | negative regulation of interleukin-17 production (GO:0032700) | 2.79837345 |
103 | regulation of gamma-delta T cell activation (GO:0046643) | 2.79404830 |
104 | reactive oxygen species biosynthetic process (GO:1903409) | 2.79282598 |
105 | activated T cell proliferation (GO:0050798) | 2.78790761 |
106 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.77813207 |
107 | macrophage activation (GO:0042116) | 2.76555139 |
108 | negative regulation of viral genome replication (GO:0045071) | 2.76526062 |
109 | regulation of mononuclear cell migration (GO:0071675) | 2.76273861 |
110 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.75762320 |
111 | response to interferon-alpha (GO:0035455) | 2.75353849 |
112 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.74652745 |
113 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.74652745 |
114 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.74320307 |
115 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.74003335 |
116 | leukocyte aggregation (GO:0070486) | 2.73634606 |
117 | monocyte chemotaxis (GO:0002548) | 2.72440981 |
118 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.72009335 |
119 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.71935266 |
120 | interferon-gamma production (GO:0032609) | 2.71612882 |
121 | regulation of immunoglobulin secretion (GO:0051023) | 2.71256735 |
122 | positive regulation of interleukin-17 production (GO:0032740) | 2.71143421 |
123 | tolerance induction (GO:0002507) | 2.70333496 |
124 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.70177275 |
125 | regulation of heat generation (GO:0031650) | 2.69961132 |
126 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.68732265 |
127 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.68554664 |
128 | negative regulation of adaptive immune response (GO:0002820) | 2.68482266 |
129 | regulation of tolerance induction (GO:0002643) | 2.68319752 |
130 | T cell migration (GO:0072678) | 2.68143313 |
131 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.67739577 |
132 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.66005663 |
133 | regulation of interleukin-17 production (GO:0032660) | 2.65094336 |
134 | neutrophil mediated immunity (GO:0002446) | 2.65028383 |
135 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.64801889 |
136 | T cell selection (GO:0045058) | 2.61811939 |
137 | myeloid leukocyte mediated immunity (GO:0002444) | 2.61486048 |
138 | regulation of regulatory T cell differentiation (GO:0045589) | 2.58875590 |
139 | positive regulation of tolerance induction (GO:0002645) | 2.58533806 |
140 | cellular response to exogenous dsRNA (GO:0071360) | 2.56404646 |
141 | negative regulation of interleukin-6 production (GO:0032715) | 2.54944489 |
142 | dendritic cell migration (GO:0036336) | 2.53708610 |
143 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.53688636 |
144 | negative regulation of B cell mediated immunity (GO:0002713) | 2.49545220 |
145 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.49545220 |
146 | regulation of T cell tolerance induction (GO:0002664) | 2.49434895 |
147 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.47660754 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.47306423 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.51755275 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.33402752 |
4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.53145273 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.19208573 |
6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.79055089 |
7 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.73036458 |
8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.69815989 |
9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.55896204 |
10 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.36193477 |
11 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.23020449 |
12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.20864847 |
13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.90753566 |
14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.66655933 |
15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.55328305 |
16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.27563602 |
17 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.18579846 |
18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.18444462 |
19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.17704352 |
20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.10003865 |
21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.98526272 |
22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.97165899 |
23 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.88027717 |
24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.85402477 |
25 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.76660494 |
26 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.75253030 |
27 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.72805345 |
28 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.70796921 |
29 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.69421697 |
30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.68701134 |
31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68259045 |
32 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.66258899 |
33 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.65545784 |
34 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.63203058 |
35 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.62008647 |
36 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.61181006 |
37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.58281450 |
38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53658569 |
39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.51679647 |
40 | * MYB_26560356_Chip-Seq_TH2_Human | 1.50044520 |
41 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.48824965 |
42 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.40617922 |
43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.36677317 |
44 | TP53_16413492_ChIP-PET_HCT116_Human | 1.35201880 |
45 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.34508154 |
46 | * MYB_26560356_Chip-Seq_TH1_Human | 1.34392570 |
47 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32484625 |
48 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31873978 |
49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.31830918 |
50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30715037 |
51 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.29297912 |
52 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28464318 |
53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.28247293 |
54 | GATA1_19941826_ChIP-Seq_K562_Human | 1.28052369 |
55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26662043 |
56 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.26100057 |
57 | * MAF_26560356_Chip-Seq_TH1_Human | 1.22706749 |
58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22421457 |
59 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.21655327 |
60 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18660981 |
61 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.17358454 |
62 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16448787 |
63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15601288 |
64 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14139556 |
65 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09493933 |
66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.08380682 |
67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06926969 |
68 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05030743 |
69 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.04871809 |
70 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04871595 |
71 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04736922 |
72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.04212709 |
73 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04203791 |
74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04181922 |
75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04181922 |
76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03941821 |
77 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03678479 |
78 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03580389 |
79 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03457106 |
80 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.01980650 |
81 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.01827076 |
82 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.01257497 |
83 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.00787850 |
84 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.00787850 |
85 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.00640981 |
86 | CJUN_26792858_Chip-Seq_BT549_Human | 1.00500434 |
87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00101160 |
88 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99928539 |
89 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99003412 |
90 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.98286050 |
91 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.96364711 |
92 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.96338079 |
93 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.95455954 |
94 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92523990 |
95 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.92435161 |
96 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.91431690 |
97 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91311837 |
98 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90183881 |
99 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90138006 |
100 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88403368 |
101 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.87082215 |
102 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86734548 |
103 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.86629893 |
104 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.86443427 |
105 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86076383 |
106 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.85530359 |
107 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85516720 |
108 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.85182763 |
109 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84726657 |
110 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.84217719 |
111 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83829038 |
112 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.83393403 |
113 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.82100501 |
114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81010416 |
115 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80869526 |
116 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.80869526 |
117 | RXR_22108803_ChIP-Seq_LS180_Human | 0.80818590 |
118 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.80591679 |
119 | STAT3_23295773_ChIP-Seq_U87_Human | 0.80553449 |
120 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.79805610 |
121 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.79803021 |
122 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79386900 |
123 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78947467 |
124 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.78540698 |
125 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.78362367 |
126 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.78001334 |
127 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.77289264 |
128 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.76566958 |
129 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.76438442 |
130 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.75111005 |
131 | MAF_26560356_Chip-Seq_TH2_Human | 0.74704182 |
132 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.73348396 |
133 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.73034081 |
134 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.71799090 |
135 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.71519771 |
136 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.71127613 |
137 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.70354102 |
138 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69816084 |
139 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.69736237 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.03150486 |
2 | MP0009785_altered_susceptibility_to | 3.51625541 |
3 | MP0003436_decreased_susceptibility_to | 3.39049995 |
4 | MP0003724_increased_susceptibility_to | 2.96905070 |
5 | MP0002148_abnormal_hypersensitivity_rea | 2.91881025 |
6 | MP0002419_abnormal_innate_immunity | 2.80526458 |
7 | MP0005000_abnormal_immune_tolerance | 2.78637502 |
8 | MP0000685_abnormal_immune_system | 2.71672479 |
9 | MP0006082_CNS_inflammation | 2.70354196 |
10 | MP0005025_abnormal_response_to | 2.69549998 |
11 | MP0001790_abnormal_immune_system | 2.68753047 |
12 | MP0005387_immune_system_phenotype | 2.68753047 |
13 | MP0003303_peritoneal_inflammation | 2.67317404 |
14 | MP0005671_abnormal_response_to | 2.46975243 |
15 | MP0001800_abnormal_humoral_immune | 2.39447755 |
16 | MP0002452_abnormal_antigen_presenting | 2.37886148 |
17 | MP0004510_myositis | 2.35160797 |
18 | MP0000569_abnormal_digit_pigmentation | 2.33208172 |
19 | MP0002723_abnormal_immune_serum | 2.29820790 |
20 | MP0002254_reproductive_system_inflammat | 2.20795042 |
21 | MP0002138_abnormal_hepatobiliary_system | 2.17549284 |
22 | MP0004947_skin_inflammation | 2.07423319 |
23 | MP0005058_abnormal_lysosome_morphology | 1.99580643 |
24 | MP0001819_abnormal_immune_cell | 1.99496820 |
25 | MP0009764_decreased_sensitivity_to | 1.98320430 |
26 | MP0002006_tumorigenesis | 1.96638106 |
27 | MP0002420_abnormal_adaptive_immunity | 1.95474179 |
28 | MP0001853_heart_inflammation | 1.91714331 |
29 | MP0005464_abnormal_platelet_physiology | 1.91365618 |
30 | MP0005451_abnormal_body_composition | 1.86190353 |
31 | MP0001533_abnormal_skeleton_physiology | 1.82583473 |
32 | MP0003646_muscle_fatigue | 1.81445694 |
33 | MP0002166_altered_tumor_susceptibility | 1.80041234 |
34 | MP0001845_abnormal_inflammatory_respons | 1.76031224 |
35 | MP0010155_abnormal_intestine_physiology | 1.73592863 |
36 | MP0003300_gastrointestinal_ulcer | 1.72117170 |
37 | MP0009278_abnormal_bone_marrow | 1.71285267 |
38 | MP0002405_respiratory_system_inflammati | 1.70083355 |
39 | MP0003191_abnormal_cellular_cholesterol | 1.69029751 |
40 | MP0004130_abnormal_muscle_cell | 1.68495934 |
41 | MP0008469_abnormal_protein_level | 1.65661057 |
42 | MP0003448_altered_tumor_morphology | 1.62245334 |
43 | MP0004883_abnormal_blood_vessel | 1.47990225 |
44 | MP0003866_abnormal_defecation | 1.45010715 |
45 | MP0003172_abnormal_lysosome_physiology | 1.42475161 |
46 | * MP0000716_abnormal_immune_system | 1.40869560 |
47 | MP0002998_abnormal_bone_remodeling | 1.39540363 |
48 | MP0005397_hematopoietic_system_phenotyp | 1.38970101 |
49 | MP0001545_abnormal_hematopoietic_system | 1.38970101 |
50 | MP0005360_urolithiasis | 1.30940851 |
51 | MP0002398_abnormal_bone_marrow | 1.30629549 |
52 | MP0005310_abnormal_salivary_gland | 1.27343817 |
53 | MP0009840_abnormal_foam_cell | 1.26802405 |
54 | MP0003828_pulmonary_edema | 1.23478206 |
55 | MP0000343_altered_response_to | 1.20798520 |
56 | MP0000858_altered_metastatic_potential | 1.20058378 |
57 | MP0009763_increased_sensitivity_to | 1.19769104 |
58 | MP0008057_abnormal_DNA_replication | 1.18944752 |
59 | MP0002277_abnormal_respiratory_mucosa | 1.18778159 |
60 | MP0003656_abnormal_erythrocyte_physiolo | 1.18680048 |
61 | MP0003690_abnormal_glial_cell | 1.18472395 |
62 | MP0009333_abnormal_splenocyte_physiolog | 1.14924508 |
63 | MP0005167_abnormal_blood-brain_barrier | 1.14285245 |
64 | MP0003453_abnormal_keratinocyte_physiol | 1.11200012 |
65 | MP0003075_altered_response_to | 1.10935937 |
66 | MP0000689_abnormal_spleen_morphology | 1.10863794 |
67 | MP0003763_abnormal_thymus_physiology | 1.10157272 |
68 | MP0003252_abnormal_bile_duct | 1.09559311 |
69 | MP0002139_abnormal_hepatobiliary_system | 1.08954380 |
70 | MP0008004_abnormal_stomach_pH | 1.08561643 |
71 | * MP0002429_abnormal_blood_cell | 1.08514216 |
72 | MP0005174_abnormal_tail_pigmentation | 1.08447206 |
73 | MP0003195_calcinosis | 1.07603327 |
74 | MP0000703_abnormal_thymus_morphology | 1.06153604 |
75 | MP0001873_stomach_inflammation | 1.05549845 |
76 | MP0004782_abnormal_surfactant_physiolog | 1.04750695 |
77 | MP0000371_diluted_coat_color | 1.02478335 |
78 | MP0000465_gastrointestinal_hemorrhage | 1.00984237 |
79 | MP0002722_abnormal_immune_system | 1.00897400 |
80 | MP0000604_amyloidosis | 0.98798116 |
81 | MP0003091_abnormal_cell_migration | 0.98707904 |
82 | MP0002396_abnormal_hematopoietic_system | 0.97407992 |
83 | MP0001663_abnormal_digestive_system | 0.96612689 |
84 | MP0005164_abnormal_response_to | 0.96567611 |
85 | MP0004484_altered_response_of | 0.95110640 |
86 | MP0003183_abnormal_peptide_metabolism | 0.94680200 |
87 | MP0002933_joint_inflammation | 0.94616028 |
88 | MP0003566_abnormal_cell_adhesion | 0.92508315 |
89 | MP0005390_skeleton_phenotype | 0.91765000 |
90 | MP0005166_decreased_susceptibility_to | 0.89363572 |
91 | MP0002132_abnormal_respiratory_system | 0.88567861 |
92 | MP0003045_fibrosis | 0.87608107 |
93 | MP0010352_gastrointestinal_tract_polyps | 0.87348051 |
94 | MP0000609_abnormal_liver_physiology | 0.86774586 |
95 | MP0004043_abnormal_pH_regulation | 0.86567701 |
96 | MP0008961_abnormal_basal_metabolism | 0.86536622 |
97 | MP0000249_abnormal_blood_vessel | 0.86415786 |
98 | MP0009115_abnormal_fat_cell | 0.84801270 |
99 | MP0001958_emphysema | 0.83489458 |
100 | MP0008438_abnormal_cutaneous_collagen | 0.81958102 |
101 | MP0000015_abnormal_ear_pigmentation | 0.80916789 |
102 | MP0002136_abnormal_kidney_physiology | 0.80560964 |
103 | MP0000767_abnormal_smooth_muscle | 0.79981884 |
104 | MP0005076_abnormal_cell_differentiation | 0.79807729 |
105 | MP0010307_abnormal_tumor_latency | 0.79596415 |
106 | MP0003186_abnormal_redox_activity | 0.79036304 |
107 | MP0006054_spinal_hemorrhage | 0.77248208 |
108 | MP0001851_eye_inflammation | 0.75832127 |
109 | MP0001501_abnormal_sleep_pattern | 0.74820020 |
110 | MP0005266_abnormal_metabolism | 0.74494987 |
111 | MP0004381_abnormal_hair_follicle | 0.72534421 |
112 | MP0008260_abnormal_autophagy | 0.71860794 |
113 | MP0005023_abnormal_wound_healing | 0.70799450 |
114 | MP0001879_abnormal_lymphatic_vessel | 0.70772280 |
115 | MP0005257_abnormal_intraocular_pressure | 0.69828824 |
116 | MP0002332_abnormal_exercise_endurance | 0.69470391 |
117 | MP0004808_abnormal_hematopoietic_stem | 0.69139425 |
118 | MP0009765_abnormal_xenobiotic_induced | 0.68458460 |
119 | MP0002928_abnormal_bile_duct | 0.67754292 |
120 | MP0005365_abnormal_bile_salt | 0.67659324 |
121 | MP0005376_homeostasis/metabolism_phenot | 0.67535394 |
122 | MP0002168_other_aberrant_phenotype | 0.65641142 |
123 | MP0005408_hypopigmentation | 0.65366552 |
124 | MP0003221_abnormal_cardiomyocyte_apopto | 0.62981407 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 6.08246200 |
2 | Recurrent abscess formation (HP:0002722) | 6.03382217 |
3 | Recurrent bacterial skin infections (HP:0005406) | 5.83131517 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.06212989 |
5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.63423586 |
6 | Stomatitis (HP:0010280) | 4.58691313 |
7 | Mediastinal lymphadenopathy (HP:0100721) | 4.40581758 |
8 | Abnormality of macrophages (HP:0004311) | 4.33615078 |
9 | Autoimmune thrombocytopenia (HP:0001973) | 3.96170420 |
10 | Recurrent skin infections (HP:0001581) | 3.95100227 |
11 | Recurrent fungal infections (HP:0002841) | 3.91077448 |
12 | Gingivitis (HP:0000230) | 3.88549678 |
13 | Orchitis (HP:0100796) | 3.85810510 |
14 | Retrobulbar optic neuritis (HP:0100654) | 3.85636998 |
15 | Optic neuritis (HP:0100653) | 3.85636998 |
16 | Myositis (HP:0100614) | 3.71737319 |
17 | Vasculitis (HP:0002633) | 3.60064072 |
18 | Prostate neoplasm (HP:0100787) | 3.58893842 |
19 | Myocardial infarction (HP:0001658) | 3.50046238 |
20 | Recurrent viral infections (HP:0004429) | 3.49391249 |
21 | Thick nail (HP:0001805) | 3.39790431 |
22 | Periodontitis (HP:0000704) | 3.35493225 |
23 | Systemic lupus erythematosus (HP:0002725) | 3.27463400 |
24 | Genetic anticipation (HP:0003743) | 3.22615159 |
25 | Vacuolated lymphocytes (HP:0001922) | 3.19880547 |
26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.19721556 |
27 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.19721556 |
28 | Increased IgM level (HP:0003496) | 3.17949265 |
29 | Pulmonary infiltrates (HP:0002113) | 3.10657587 |
30 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.07723866 |
31 | Tetraparesis (HP:0002273) | 2.98577488 |
32 | Recurrent bronchitis (HP:0002837) | 2.97302632 |
33 | Pustule (HP:0200039) | 2.96699271 |
34 | Gingival bleeding (HP:0000225) | 2.94246698 |
35 | Gastrointestinal infarctions (HP:0005244) | 2.92774958 |
36 | Abnormality of the fingertips (HP:0001211) | 2.88582244 |
37 | Hematochezia (HP:0002573) | 2.88457721 |
38 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.85058896 |
39 | Abnormality of T cells (HP:0002843) | 2.80768449 |
40 | Leukocytosis (HP:0001974) | 2.76943755 |
41 | Joint hemorrhage (HP:0005261) | 2.75646468 |
42 | Obstructive lung disease (HP:0006536) | 2.70894467 |
43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.70894467 |
44 | Arterial thrombosis (HP:0004420) | 2.69909020 |
45 | Basal ganglia calcification (HP:0002135) | 2.66336908 |
46 | Increased IgE level (HP:0003212) | 2.59836571 |
47 | Chest pain (HP:0100749) | 2.59684740 |
48 | Interstitial pulmonary disease (HP:0006530) | 2.51858853 |
49 | Premature loss of primary teeth (HP:0006323) | 2.47758477 |
50 | Amyloidosis (HP:0011034) | 2.47084879 |
51 | Hemoptysis (HP:0002105) | 2.45881887 |
52 | Osteomyelitis (HP:0002754) | 2.45471601 |
53 | Eosinophilia (HP:0001880) | 2.42583061 |
54 | Keratoconjunctivitis sicca (HP:0001097) | 2.40986665 |
55 | Glomerulonephritis (HP:0000099) | 2.40242991 |
56 | Osteolytic defects of the hand bones (HP:0009699) | 2.39588235 |
57 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.39588235 |
58 | Prolonged bleeding time (HP:0003010) | 2.38673180 |
59 | Urticaria (HP:0001025) | 2.38529553 |
60 | Meningitis (HP:0001287) | 2.37806927 |
61 | Keratoconjunctivitis (HP:0001096) | 2.37114464 |
62 | Pulmonary embolism (HP:0002204) | 2.37079958 |
63 | Esophageal varix (HP:0002040) | 2.37009032 |
64 | Axonal loss (HP:0003447) | 2.35584970 |
65 | Colitis (HP:0002583) | 2.29694000 |
66 | Gastrointestinal inflammation (HP:0004386) | 2.28747035 |
67 | Cellulitis (HP:0100658) | 2.27826180 |
68 | Recurrent pneumonia (HP:0006532) | 2.26099525 |
69 | Clumsiness (HP:0002312) | 2.25819663 |
70 | Abnormality of the prostate (HP:0008775) | 2.24738461 |
71 | Increased cerebral lipofuscin (HP:0011813) | 2.23537959 |
72 | Abnormality of the endocardium (HP:0004306) | 2.22366848 |
73 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.21249079 |
74 | Abnormality of T cell number (HP:0011839) | 2.20529513 |
75 | Nephritis (HP:0000123) | 2.19736935 |
76 | Hypergammaglobulinemia (HP:0010702) | 2.19333496 |
77 | Stomach cancer (HP:0012126) | 2.18663896 |
78 | Abnormality of T cell physiology (HP:0011840) | 2.17416394 |
79 | Joint swelling (HP:0001386) | 2.15801522 |
80 | Abnormality of the pleura (HP:0002103) | 2.14657545 |
81 | Hydroxyprolinuria (HP:0003080) | 2.13240082 |
82 | Abnormality of proline metabolism (HP:0010907) | 2.13240082 |
83 | Peritonitis (HP:0002586) | 2.13032187 |
84 | Bone pain (HP:0002653) | 2.09694338 |
85 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.09313764 |
86 | Chronic diarrhea (HP:0002028) | 2.08659269 |
87 | Chronic otitis media (HP:0000389) | 2.08450711 |
88 | Hypochromic anemia (HP:0001931) | 2.06491845 |
89 | Granulocytopenia (HP:0001913) | 2.05179276 |
90 | Spontaneous hematomas (HP:0007420) | 2.04448770 |
91 | Panhypogammaglobulinemia (HP:0003139) | 2.03481809 |
92 | Epistaxis (HP:0000421) | 2.02870549 |
93 | Recurrent lower respiratory tract infections (HP:0002783) | 2.00535690 |
94 | Vertigo (HP:0002321) | 1.99468915 |
95 | T lymphocytopenia (HP:0005403) | 1.99442503 |
96 | Anorexia (HP:0002039) | 1.96515356 |
97 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.95677947 |
98 | Nasal polyposis (HP:0100582) | 1.94579056 |
99 | Hemorrhage of the eye (HP:0011885) | 1.93523867 |
100 | Hyperventilation (HP:0002883) | 1.93442531 |
101 | Inflammation of the large intestine (HP:0002037) | 1.92387748 |
102 | Nausea (HP:0002018) | 1.88785933 |
103 | Progressive cerebellar ataxia (HP:0002073) | 1.88347967 |
104 | Pulmonary artery stenosis (HP:0004415) | 1.87916681 |
105 | Abnormality of eosinophils (HP:0001879) | 1.87822899 |
106 | Abnormality of the pericardium (HP:0001697) | 1.86893302 |
107 | Protruding tongue (HP:0010808) | 1.86455123 |
108 | Autoimmune hemolytic anemia (HP:0001890) | 1.85722059 |
109 | Hemiplegia (HP:0002301) | 1.85476332 |
110 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.84398443 |
111 | Abnormality of the peritoneum (HP:0002585) | 1.84263695 |
112 | Cheilitis (HP:0100825) | 1.83888487 |
113 | Gangrene (HP:0100758) | 1.83555757 |
114 | Alveolar cell carcinoma (HP:0006519) | 1.83318212 |
115 | Postural instability (HP:0002172) | 1.83178229 |
116 | Complement deficiency (HP:0004431) | 1.83132014 |
117 | Abnormality of the nasal mucosa (HP:0000433) | 1.82947392 |
118 | Skin ulcer (HP:0200042) | 1.82323885 |
119 | Abnormality of the common coagulation pathway (HP:0010990) | 1.82228287 |
120 | Lymphopenia (HP:0001888) | 1.82060138 |
121 | Gastrointestinal stroma tumor (HP:0100723) | 1.81623118 |
122 | Menorrhagia (HP:0000132) | 1.80725696 |
123 | Dysmetric saccades (HP:0000641) | 1.79825166 |
124 | Vertebral compression fractures (HP:0002953) | 1.79743984 |
125 | Arthralgia (HP:0002829) | 1.79643187 |
126 | Pathologic fracture (HP:0002756) | 1.79426558 |
127 | Encephalitis (HP:0002383) | 1.79327878 |
128 | Episodic fever (HP:0001954) | 1.79069658 |
129 | IgA deficiency (HP:0002720) | 1.78516710 |
130 | Slow saccadic eye movements (HP:0000514) | 1.78502813 |
131 | Agammaglobulinemia (HP:0004432) | 1.77864897 |
132 | Viral hepatitis (HP:0006562) | 1.77861545 |
133 | Recurrent sinusitis (HP:0011108) | 1.76904283 |
134 | Porencephaly (HP:0002132) | 1.76777631 |
135 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.75515103 |
136 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.75353902 |
137 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.75353902 |
138 | Subacute progressive viral hepatitis (HP:0006572) | 1.74965702 |
139 | Keratitis (HP:0000491) | 1.73689086 |
140 | Facial diplegia (HP:0001349) | 1.71995549 |
141 | Bronchitis (HP:0012387) | 1.71501846 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 5.17386589 |
2 | IRAK3 | 3.53620324 |
3 | TYK2 | 3.34415751 |
4 | TBK1 | 3.31268890 |
5 | IKBKE | 3.20116799 |
6 | IRAK4 | 3.02463724 |
7 | JAK3 | 2.95060758 |
8 | IKBKB | 2.67526702 |
9 | TXK | 2.59231919 |
10 | ACVR1B | 2.48071300 |
11 | RIPK4 | 2.43530473 |
12 | JAK1 | 2.39214232 |
13 | MAP3K13 | 2.23647883 |
14 | MAP4K1 | 2.12640631 |
15 | TAOK3 | 2.07643734 |
16 | CHUK | 2.04776752 |
17 | KIT | 1.84700819 |
18 | BLK | 1.79158069 |
19 | PBK | 1.69082299 |
20 | FGFR4 | 1.66835344 |
21 | TGFBR2 | 1.65741510 |
22 | ERN1 | 1.56344880 |
23 | ZAP70 | 1.43985225 |
24 | CSK | 1.41611907 |
25 | EPHA3 | 1.40972439 |
26 | EPHB1 | 1.40955174 |
27 | NEK9 | 1.40144842 |
28 | GRK6 | 1.30644087 |
29 | FGFR3 | 1.29003040 |
30 | EIF2AK2 | 1.26705188 |
31 | TNK2 | 1.25822933 |
32 | CDC42BPA | 1.24857914 |
33 | MAP3K7 | 1.16792949 |
34 | TEC | 1.16610013 |
35 | MST1R | 1.16515035 |
36 | HCK | 1.14024629 |
37 | PTK2B | 1.12901357 |
38 | JAK2 | 1.12878530 |
39 | RPS6KA4 | 1.11226902 |
40 | PRPF4B | 1.10950393 |
41 | INSRR | 1.09730457 |
42 | SGK2 | 1.08824314 |
43 | LCK | 1.07950047 |
44 | IRAK1 | 1.07140688 |
45 | MARK2 | 1.07077290 |
46 | CSF1R | 1.04264311 |
47 | PIM2 | 1.02730019 |
48 | SYK | 1.01691944 |
49 | NUAK1 | 1.01563905 |
50 | WNK1 | 1.00798661 |
51 | NLK | 1.00536509 |
52 | MAP3K2 | 1.00347347 |
53 | PIM1 | 0.98157368 |
54 | AKT3 | 0.94957299 |
55 | BTK | 0.94730995 |
56 | TRPM7 | 0.93336382 |
57 | CDK12 | 0.91746251 |
58 | LYN | 0.90898418 |
59 | MAP3K1 | 0.90054987 |
60 | MELK | 0.87051363 |
61 | MARK3 | 0.86259025 |
62 | TAOK1 | 0.86099876 |
63 | CAMKK2 | 0.85601758 |
64 | STK3 | 0.85407587 |
65 | ITK | 0.85146415 |
66 | STK10 | 0.84508236 |
67 | SGK3 | 0.83957491 |
68 | TRIB3 | 0.83643720 |
69 | DAPK2 | 0.83122566 |
70 | PTK6 | 0.81237642 |
71 | STK4 | 0.80786936 |
72 | CAMK1D | 0.80255267 |
73 | MST4 | 0.77962529 |
74 | BMPR2 | 0.77944235 |
75 | PDK1 | 0.76185464 |
76 | MAP3K6 | 0.75817996 |
77 | GRK7 | 0.75799121 |
78 | SIK1 | 0.73688848 |
79 | RIPK1 | 0.72162834 |
80 | TTN | 0.71417478 |
81 | BMX | 0.70784032 |
82 | ABL1 | 0.66913364 |
83 | MAPK7 | 0.66799417 |
84 | MAPK12 | 0.66538249 |
85 | FGR | 0.65736524 |
86 | FLT3 | 0.65709974 |
87 | MAP3K11 | 0.64984010 |
88 | KSR2 | 0.64368186 |
89 | STK38 | 0.63683839 |
90 | IRAK2 | 0.63651215 |
91 | MAP3K10 | 0.63535959 |
92 | ADRBK1 | 0.62302754 |
93 | STK11 | 0.61649427 |
94 | MAP2K6 | 0.60909765 |
95 | ERBB4 | 0.57717539 |
96 | PRKAA2 | 0.57236885 |
97 | EGFR | 0.56693822 |
98 | ABL2 | 0.56081044 |
99 | MAP2K3 | 0.55672676 |
100 | PRKCQ | 0.55411624 |
101 | PDPK1 | 0.55341795 |
102 | SGK494 | 0.55137478 |
103 | SGK223 | 0.55137478 |
104 | RPS6KA6 | 0.54191341 |
105 | PDGFRB | 0.53256869 |
106 | MAP3K3 | 0.53144152 |
107 | LATS1 | 0.53028420 |
108 | FRK | 0.52525692 |
109 | MAP3K5 | 0.52332032 |
110 | PIK3CG | 0.51532199 |
111 | CAMKK1 | 0.51270604 |
112 | YES1 | 0.49937049 |
113 | PRKCD | 0.49233690 |
114 | RET | 0.48505029 |
115 | CAMK4 | 0.48176689 |
116 | CDK6 | 0.46837146 |
117 | PKN1 | 0.45632873 |
118 | MATK | 0.44605035 |
119 | IGF1R | 0.43021597 |
120 | SIK2 | 0.42120798 |
121 | NME2 | 0.41896933 |
122 | ZAK | 0.40454119 |
123 | PIK3CA | 0.39986261 |
124 | GSK3A | 0.39296791 |
125 | MAPKAPK2 | 0.38097201 |
126 | CAMK1G | 0.35626474 |
127 | INSR | 0.34170732 |
128 | SIK3 | 0.32340152 |
129 | ADRBK2 | 0.31328669 |
130 | FES | 0.29840290 |
131 | MOS | 0.29708077 |
132 | HIPK2 | 0.28702380 |
133 | MAPK11 | 0.27500935 |
134 | KDR | 0.27432831 |
135 | TIE1 | 0.23704293 |
136 | BMPR1B | 0.23139755 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.22870242 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.08506833 |
3 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.99783937 |
4 | Allograft rejection_Homo sapiens_hsa05330 | 2.81189768 |
5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.79528732 |
6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.75598919 |
7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.64350569 |
8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.46306192 |
9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.31235662 |
10 | Measles_Homo sapiens_hsa05162 | 2.30921716 |
11 | Malaria_Homo sapiens_hsa05144 | 2.26703253 |
12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.25461862 |
13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.22884715 |
14 | Legionellosis_Homo sapiens_hsa05134 | 2.21250528 |
15 | Pertussis_Homo sapiens_hsa05133 | 2.11535955 |
16 | * TNF signaling pathway_Homo sapiens_hsa04668 | 2.00961365 |
17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.00232693 |
18 | Influenza A_Homo sapiens_hsa05164 | 1.87353606 |
19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.86105091 |
20 | Tuberculosis_Homo sapiens_hsa05152 | 1.79782980 |
21 | Asthma_Homo sapiens_hsa05310 | 1.72800202 |
22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.71688046 |
23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.67140349 |
24 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.66039598 |
25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.63003567 |
26 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.51814153 |
27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.51519151 |
28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.43387555 |
29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.42473990 |
30 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.39023918 |
31 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36294053 |
32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.34860266 |
33 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.30787302 |
34 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.26077383 |
35 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.23056614 |
36 | * Apoptosis_Homo sapiens_hsa04210 | 1.22716063 |
37 | Hepatitis C_Homo sapiens_hsa05160 | 1.22450549 |
38 | Salmonella infection_Homo sapiens_hsa05132 | 1.17638204 |
39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14121845 |
40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.08543310 |
41 | Lysosome_Homo sapiens_hsa04142 | 1.08053166 |
42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.07779297 |
43 | Phagosome_Homo sapiens_hsa04145 | 1.04899517 |
44 | Hepatitis B_Homo sapiens_hsa05161 | 1.04456941 |
45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01674982 |
46 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.98206903 |
47 | Viral myocarditis_Homo sapiens_hsa05416 | 0.97847840 |
48 | Amoebiasis_Homo sapiens_hsa05146 | 0.94419587 |
49 | Shigellosis_Homo sapiens_hsa05131 | 0.93020481 |
50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.92223528 |
51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90407553 |
52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.90158295 |
53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.89373834 |
54 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.87163903 |
55 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86748193 |
56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.82551988 |
57 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.81990345 |
58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.77174222 |
59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.74925838 |
60 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74824551 |
61 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.74792630 |
62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73991092 |
63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72771470 |
64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72183692 |
65 | ABC transporters_Homo sapiens_hsa02010 | 0.70759390 |
66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70580586 |
67 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70221498 |
68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68818203 |
69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68195810 |
70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67950021 |
71 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67540861 |
72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65258817 |
73 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65057414 |
74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63194750 |
75 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62776515 |
76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61996968 |
77 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.60422471 |
78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60143376 |
79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.58044674 |
80 | Insulin resistance_Homo sapiens_hsa04931 | 0.57814924 |
81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57105742 |
82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57062365 |
83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55913397 |
84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54565774 |
85 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.53679119 |
86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52911760 |
87 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52742766 |
88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47302805 |
89 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45892017 |
90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45735773 |
91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.44659528 |
92 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.43083955 |
93 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.42921530 |
94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42708729 |
95 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41119317 |
96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41057935 |
97 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.40722784 |
98 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.40120296 |
99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39863154 |
100 | Platelet activation_Homo sapiens_hsa04611 | 0.39411207 |
101 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38916231 |
102 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38878181 |
103 | Peroxisome_Homo sapiens_hsa04146 | 0.38564808 |
104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37788977 |
105 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.36803617 |
106 | Prion diseases_Homo sapiens_hsa05020 | 0.36020068 |
107 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35408357 |
108 | Histidine metabolism_Homo sapiens_hsa00340 | 0.33461849 |
109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.33246590 |
110 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33023999 |
111 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32601413 |
112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32503155 |
113 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32015627 |
114 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.29819306 |
115 | Prostate cancer_Homo sapiens_hsa05215 | 0.29718779 |
116 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.28642328 |
117 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.27702938 |
118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.27247286 |
119 | HTLV-I infection_Homo sapiens_hsa05166 | 0.25915334 |
120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.25598990 |
121 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.25348140 |
122 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.22186418 |
123 | Lysine degradation_Homo sapiens_hsa00310 | 0.21609923 |
124 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.21563467 |
125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21332642 |
126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.21101135 |
127 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.21006798 |
128 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.20784914 |
129 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.19843400 |
130 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.19824276 |